Global Flu Shots market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Flu Shots Market Size and Outlook 2025-31

The global Flu Shots market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. United States market for Flu Shots is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Flu Shots is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Flu Shots is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Flu Shots players cover GSK, SINOVAC, CHANGSHENG, CCBIO, ALEPH BIOMEDICAL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Flu Shots Industry Forecast looks at past sales and reviews total world Flu Shots sales in 2024, providing a comprehensive analysis by region and market sector of projected Flu Shots sales for 2025 through 2031. With Flu Shots sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu Shots industry. This Insight Report provides a comprehensive analysis of the global Flu Shots landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu Shots portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Flu Shots market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu Shots and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu Shots. This report presents a comprehensive overview, market shares, and growth opportunities of Flu Shots market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Influenza Virus Split Vaccines &nbsp;&nbsp;&nbsp; Influenza Virus Subunit Vaccines &nbsp;&nbsp;&nbsp; Influenza Whole Virus Vaccines Segmentation by Application: &nbsp;&nbsp;&nbsp; Avian Influenza Virus-A &nbsp;&nbsp;&nbsp; Avian Influenza Virus-B This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; SINOVAC &nbsp;&nbsp;&nbsp; CHANGSHENG &nbsp;&nbsp;&nbsp; CCBIO &nbsp;&nbsp;&nbsp; ALEPH BIOMEDICAL &nbsp;&nbsp;&nbsp; SANOFI &nbsp;&nbsp;&nbsp; LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT &nbsp;&nbsp;&nbsp; SIOBP &nbsp;&nbsp;&nbsp; HUALAN BIO &nbsp;&nbsp;&nbsp; TIANYUAN BIO-PHARMA &nbsp;&nbsp;&nbsp; VAXTEC Key Questions Addressed in this Report What is the 10-year outlook for the global Flu Shots market? What factors are driving Flu Shots market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Flu Shots market opportunities vary by end market size? How does Flu Shots break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Flu Shots Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Flu Shots by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Flu Shots by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Flu Shots Segment by Type &nbsp;2.2.1 Influenza Virus Split Vaccines &nbsp;2.2.2 Influenza Virus Subunit Vaccines &nbsp;2.2.3 Influenza Whole Virus Vaccines &nbsp;2.3 Flu Shots Sales by Type &nbsp;2.3.1 Global Flu Shots Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Flu Shots Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Flu Shots Sale Price by Type (2020-2025) &nbsp;2.4 Flu Shots Segment by Application &nbsp;2.4.1 Avian Influenza Virus-A &nbsp;2.4.2 Avian Influenza Virus-B &nbsp;2.5 Flu Shots Sales by Application &nbsp;2.5.1 Global Flu Shots Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Flu Shots Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Flu Shots Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Flu Shots Breakdown Data by Company &nbsp;3.1.1 Global Flu Shots Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Flu Shots Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Flu Shots Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Flu Shots Revenue by Company (2020-2025) &nbsp;3.2.2 Global Flu Shots Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Flu Shots Sale Price by Company &nbsp;3.4 Key Manufacturers Flu Shots Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Flu Shots Product Location Distribution &nbsp;3.4.2 Players Flu Shots Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Flu Shots by Geographic Region &nbsp;4.1 World Historic Flu Shots Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Flu Shots Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Flu Shots Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Flu Shots Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Flu Shots Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Flu Shots Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Flu Shots Sales Growth &nbsp;4.4 APAC Flu Shots Sales Growth &nbsp;4.5 Europe Flu Shots Sales Growth &nbsp;4.6 Middle East & Africa Flu Shots Sales Growth 5 Americas &nbsp;5.1 Americas Flu Shots Sales by Country &nbsp;5.1.1 Americas Flu Shots Sales by Country (2020-2025) &nbsp;5.1.2 Americas Flu Shots Revenue by Country (2020-2025) &nbsp;5.2 Americas Flu Shots Sales by Type (2020-2025) &nbsp;5.3 Americas Flu Shots Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Flu Shots Sales by Region &nbsp;6.1.1 APAC Flu Shots Sales by Region (2020-2025) &nbsp;6.1.2 APAC Flu Shots Revenue by Region (2020-2025) &nbsp;6.2 APAC Flu Shots Sales by Type (2020-2025) &nbsp;6.3 APAC Flu Shots Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Flu Shots by Country &nbsp;7.1.1 Europe Flu Shots Sales by Country (2020-2025) &nbsp;7.1.2 Europe Flu Shots Revenue by Country (2020-2025) &nbsp;7.2 Europe Flu Shots Sales by Type (2020-2025) &nbsp;7.3 Europe Flu Shots Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Flu Shots by Country &nbsp;8.1.1 Middle East & Africa Flu Shots Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Flu Shots Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Flu Shots Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Flu Shots Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Flu Shots &nbsp;10.3 Manufacturing Process Analysis of Flu Shots &nbsp;10.4 Industry Chain Structure of Flu Shots 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Flu Shots Distributors &nbsp;11.3 Flu Shots Customer 12 World Forecast Review for Flu Shots by Geographic Region &nbsp;12.1 Global Flu Shots Market Size Forecast by Region &nbsp;12.1.1 Global Flu Shots Forecast by Region (2026-2031) &nbsp;12.1.2 Global Flu Shots Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Flu Shots Forecast by Type (2026-2031) &nbsp;12.7 Global Flu Shots Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 GSK &nbsp;13.1.1 GSK Company Information &nbsp;13.1.2 GSK Flu Shots Product Portfolios and Specifications &nbsp;13.1.3 GSK Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 GSK Main Business Overview &nbsp;13.1.5 GSK Latest Developments &nbsp;13.2 SINOVAC &nbsp;13.2.1 SINOVAC Company Information &nbsp;13.2.2 SINOVAC Flu Shots Product Portfolios and Specifications &nbsp;13.2.3 SINOVAC Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 SINOVAC Main Business Overview &nbsp;13.2.5 SINOVAC Latest Developments &nbsp;13.3 CHANGSHENG &nbsp;13.3.1 CHANGSHENG Company Information &nbsp;13.3.2 CHANGSHENG Flu Shots Product Portfolios and Specifications &nbsp;13.3.3 CHANGSHENG Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 CHANGSHENG Main Business Overview &nbsp;13.3.5 CHANGSHENG Latest Developments &nbsp;13.4 CCBIO &nbsp;13.4.1 CCBIO Company Information &nbsp;13.4.2 CCBIO Flu Shots Product Portfolios and Specifications &nbsp;13.4.3 CCBIO Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 CCBIO Main Business Overview &nbsp;13.4.5 CCBIO Latest Developments &nbsp;13.5 ALEPH BIOMEDICAL &nbsp;13.5.1 ALEPH BIOMEDICAL Company Information &nbsp;13.5.2 ALEPH BIOMEDICAL Flu Shots Product Portfolios and Specifications &nbsp;13.5.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 ALEPH BIOMEDICAL Main Business Overview &nbsp;13.5.5 ALEPH BIOMEDICAL Latest Developments &nbsp;13.6 SANOFI &nbsp;13.6.1 SANOFI Company Information &nbsp;13.6.2 SANOFI Flu Shots Product Portfolios and Specifications &nbsp;13.6.3 SANOFI Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 SANOFI Main Business Overview &nbsp;13.6.5 SANOFI Latest Developments &nbsp;13.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT &nbsp;13.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information &nbsp;13.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolios and Specifications &nbsp;13.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Main Business Overview &nbsp;13.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Latest Developments &nbsp;13.8 SIOBP &nbsp;13.8.1 SIOBP Company Information &nbsp;13.8.2 SIOBP Flu Shots Product Portfolios and Specifications &nbsp;13.8.3 SIOBP Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 SIOBP Main Business Overview &nbsp;13.8.5 SIOBP Latest Developments &nbsp;13.9 HUALAN BIO &nbsp;13.9.1 HUALAN BIO Company Information &nbsp;13.9.2 HUALAN BIO Flu Shots Product Portfolios and Specifications &nbsp;13.9.3 HUALAN BIO Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 HUALAN BIO Main Business Overview &nbsp;13.9.5 HUALAN BIO Latest Developments &nbsp;13.10 TIANYUAN BIO-PHARMA &nbsp;13.10.1 TIANYUAN BIO-PHARMA Company Information &nbsp;13.10.2 TIANYUAN BIO-PHARMA Flu Shots Product Portfolios and Specifications &nbsp;13.10.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 TIANYUAN BIO-PHARMA Main Business Overview &nbsp;13.10.5 TIANYUAN BIO-PHARMA Latest Developments &nbsp;13.11 VAXTEC &nbsp;13.11.1 VAXTEC Company Information &nbsp;13.11.2 VAXTEC Flu Shots Product Portfolios and Specifications &nbsp;13.11.3 VAXTEC Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 VAXTEC Main Business Overview &nbsp;13.11.5 VAXTEC Latest Developments 14 Research Findings and Conclusion

Report	Global Flu Shots Market Growth 2025-2031
Selected License	Single ID:LPI23824

Buyer Information

Order Summary